Table 4: Adverse events reported by >5% of patients in each group.

Adverse eventsNumber of patients (%)
JLT (N = 56)Placebo (N = 55)

Abdominal pain3 (5.36)3 (5.45)
Dyspepsia5 (8.93)1 (1.82)
Diarrhea1 (1.79)3 (5.45)
Dizziness3 (5.36)7 (12.73)
Back pain1 (1.79)5 (9.09)
Joint pain2 (3.57)4 (7.27)